Stocks News

LAST PRICE
58.4850
TODAY'S CHANGE (%)
Trending Down-4.7550 (-7.5190%)

Bid / Lots
58.4500/ 4
Ask / Lots
58.5300/ 5
Open / Previous Close
62.1700 / 63.2400
Day Range
Low 58.4000
High 62.5000
52 Week Range
Low 56.0500
High 100.7700
Volume
1,407,961
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Apr 15, 2024
- Sector Update: Health Care Stocks Advance Premarket Monday, from 9:14AM ET on Monday Apr 15, 2024 by MT Newswires
  9:14AM ET on Monday Apr 15, 2024 by MT Newswires
  Companies Mentioned: EXAS, IBB, XLV, RARE, NMRA
  09:14 AM EDT, 04/15/2024 (MT Newswires) -- Health care stocks were advancing in premarket activity Monday as the Health Care Select Sector SPDR Fund (XLV) was up 0.6% and the iShares Biotechnology ETF (IBB) was 0.3% higher recently. Neumora Therape...
- Exact Sciences Names Aaron Bloomer CFO, from 8:12AM ET on Monday Apr 15, 2024 by MT Newswires
  8:12AM ET on Monday Apr 15, 2024 by MT Newswires
  Companies Mentioned: EXAS
  08:12 AM EDT, 04/15/2024 (MT Newswires) -- Exact Sciences (EXAS) said Monday that it has appointed Aaron Bloomer as its chief financial officer, effective May 15. Bloomer has previously held senior positions at Baxter International and 3M, Exact Sci...
- DJ Exact Sciences Taps Aaron Bloomer as Finance Chief, from 6:19AM ET on Monday Apr 15, 2024 by Dow Jones
  6:19AM ET on Monday Apr 15, 2024 by Dow Jones
  Companies Mentioned: EXAS
  
  By Sabela Ojea
  
  Exact Sciences named Aaron Bloomer as finance chief, replacing Jeff Elliott in the role.
  
  The provider of cancer screening and diagnostic tests said Monday that the appointment of Bloomer, who most recently worked at Baxter International, will be effective on May 15.
- Exact Sciences Names Aaron Bloomer as New Chief Financial Officer, from 6:00AM ET on Monday Apr 15, 2024 by Dow Jones
  6:00AM ET on Monday Apr 15, 2024 by Dow Jones
  Companies Mentioned: EXAS
  MADISON, Wis.--(BUSINESS WIRE)--April 15, 2024--
  Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today the appointment of Aaron Bloomer as chief financial officer (CFO), effective May 15, 2024.
- *DJ Exact Sciences Names Aaron Bloomer As New Chief Financial Officer >EXAS, from 6:00AM ET on Monday Apr 15, 2024 by Dow Jones
  6:00AM ET on Monday Apr 15, 2024 by Dow Jones
  Companies Mentioned: EXAS

Yesterday
- --Baird Adjusts Medpace Price Target to $454 From $446, Maintains Outperform Rating, from 10:28AM ET on Wednesday Apr 24, 2024 by MT Newswires
  10:28AM ET on Wednesday Apr 24, 2024 by MT Newswires
  Companies Mentioned: MEDP
- United Therapeutics Announces World's First Successful Xenothymokidney Transplant, from 9:00AM ET on Wednesday Apr 24, 2024 by Business Wire
  9:00AM ET on Wednesday Apr 24, 2024 by Business Wire
  Companies Mentioned: UTHR
- United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024, from 7:00AM ET on Wednesday Apr 24, 2024 by Business Wire
  7:00AM ET on Wednesday Apr 24, 2024 by Business Wire
  Companies Mentioned: UTHR
Apr 23, 2024
- United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing, from 4:39PM ET on Tuesday Apr 23, 2024 by MT Newswires
  4:39PM ET on Tuesday Apr 23, 2024 by MT Newswires
  Companies Mentioned: UTHR
- Sector Update: Health Care Stocks Rise in Afternoon Trading, from 1:51PM ET on Tuesday Apr 23, 2024 by MT Newswires
  1:51PM ET on Tuesday Apr 23, 2024 by MT Newswires
  Companies Mentioned: UNH, TLSA, BGNE
- Update: BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise, from 11:19AM ET on Tuesday Apr 23, 2024 by MT Newswires
  11:19AM ET on Tuesday Apr 23, 2024 by MT Newswires
  Companies Mentioned: BGNE
- United Therapeutics Q1 Results Could Fall Short of Market Expectations, Oppenheimer Says, from 11:06AM ET on Tuesday Apr 23, 2024 by MT Newswires
  11:06AM ET on Tuesday Apr 23, 2024 by MT Newswires
  Companies Mentioned: UTHR
- Technology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading, from 10:37AM ET on Tuesday Apr 23, 2024 by MT Newswires
  10:37AM ET on Tuesday Apr 23, 2024 by MT Newswires
  Companies Mentioned: HDB, INFY, PHI, RDY, TLK, DXF, SE, ICLK, ASLN, WNS, DUO, CAN, BQ, YQ, CMCM, BGNE
- BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer, from 9:19AM ET on Tuesday Apr 23, 2024 by MT Newswires
  9:19AM ET on Tuesday Apr 23, 2024 by MT Newswires
  Companies Mentioned: BGNE
- --Jefferies Upgrades Medpace Holdings to Buy, Price Target at $450, from 7:19AM ET on Tuesday Apr 23, 2024 by MT Newswires
  7:19AM ET on Tuesday Apr 23, 2024 by MT Newswires
  Companies Mentioned: MEDP

Exact Sciences Corp
NASDAQ:EXASUnited States

Search Criteria

Apr 15, 2024

Sector Update: Health Care Stocks Advance Premarket Monday, from 9:14AM ET on Monday Apr 15, 2024 by MT Newswires

Exact Sciences Names Aaron Bloomer CFO, from 8:12AM ET on Monday Apr 15, 2024 by MT Newswires

DJ Exact Sciences Taps Aaron Bloomer as Finance Chief, from 6:19AM ET on Monday Apr 15, 2024 by Dow Jones

Exact Sciences Names Aaron Bloomer as New Chief Financial Officer, from 6:00AM ET on Monday Apr 15, 2024 by Dow Jones

*DJ Exact Sciences Names Aaron Bloomer As New Chief Financial Officer >EXAS, from 6:00AM ET on Monday Apr 15, 2024 by Dow Jones

Peers Headlines

Yesterday

--Baird Adjusts Medpace Price Target to $454 From $446, Maintains Outperform Rating, from 10:28AM ET on Wednesday Apr 24, 2024 by MT Newswires

United Therapeutics Announces World's First Successful Xenothymokidney Transplant, from 9:00AM ET on Wednesday Apr 24, 2024 by Business Wire

United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024, from 7:00AM ET on Wednesday Apr 24, 2024 by Business Wire

Apr 23, 2024

United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing, from 4:39PM ET on Tuesday Apr 23, 2024 by MT Newswires

Sector Update: Health Care Stocks Rise in Afternoon Trading, from 1:51PM ET on Tuesday Apr 23, 2024 by MT Newswires

Update: BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise, from 11:19AM ET on Tuesday Apr 23, 2024 by MT Newswires

United Therapeutics Q1 Results Could Fall Short of Market Expectations, Oppenheimer Says, from 11:06AM ET on Tuesday Apr 23, 2024 by MT Newswires

Technology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading, from 10:37AM ET on Tuesday Apr 23, 2024 by MT Newswires

BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer, from 9:19AM ET on Tuesday Apr 23, 2024 by MT Newswires

--Jefferies Upgrades Medpace Holdings to Buy, Price Target at $450, from 7:19AM ET on Tuesday Apr 23, 2024 by MT Newswires